Organ donation and treatment of the multi-organ donor

Current Problems in Surgery

Volumn 40, Issue 5, 2003, Pages 266-310

  Tuttle Newhall, Janet E ^a   Collins, Bradley H ^a   Kuo, Paul C ^a   Schoeder, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BRAIN DEATH; CADAVER DONOR; COMORBIDITY; HEALTH BEHAVIOR; HEART BEAT; HEMODYNAMICS; HUMAN; INFORMED CONSENT; INTENSIVE CARE; LIVING DONOR; MEDICOLEGAL ASPECT; MORTALITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT CARE; PATIENT SELECTION; PUBLIC HEALTH; REVIEW; SEROLOGY; TREATMENT INDICATION; XENOTRANSPLANTATION;

EID: 0038367789     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-3840(03)00011-X     Document Type: Review

References (156)

1. Sharing, United Network of Organ Sharing, Critical Data. 2002.
2. The United States Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients. Annual Report: 2001. Washington (DC) : Department of Health and Human Services, Health Resources and Services Administration; 2001:p.1-41.
3. Evans RW, Orians CE, Ascher NL, The potential supply of organ donors: an assessment of the efficacy of organ procurement efforts in the United States. JAMA 1992;267:239-46.
4. Evans RW. The actual and potential supply of organ donors in the United States. Clin Transpl 1990:329-41.
5. Wendler D, Dickert N. The consent process for cadaveric organ procurement: How does it work? How can it be improved?. JAMA 2001;285:329-33.
6. Arnold R, Bartlett S, Bernat J, et al. Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation 2002;73:1361-7.
7. The Gallup Organization. The American public's attitudes toward organ donation and transplantation. Boston: The Partnership for Organ Donation Inc; 1993.
8. Siminoff LA, Arnold AR, Caplan AL, et al. Public policy governing organ and tissue procurement in the United States. Ann Intern Med 1995;123:10-7.
9. Siminoff LA, Gordon N, Hewlett J, et al. Factors influencing families consent for solid organs for transplantation. JAMA 2001;286:71-7.
10. Jordon L. Pitt Total Care Coordinator Data, Executive Director's Report. Carolina Donor Services Annual Report pg 2, 2/17/00.
11. Gortmaker SL, Beasley CL, Sheehy E, et al. Improving the request process to increase family consent for organ donation. J Transpl Coordination 1998;8:210-7.
12. Phadke KD, Anandh U. Ethics of paid organ donation. Pediatr Nephrol 2002;17: 309-11.
13. Childress J. Ethical criteria for procuring and distributing organs for transplantation. J Health Polit Policy Law 1989;14:87-113.
14. Kluge EH. Decisions about organ donation should rest with potential donors, not next of kin. CMAJ 1997;157:160-1.
15. Cohen B, Wight C. A European perspective on organ procurement: breaking down the barriers to organ donation. Transplantation 1999;68:985-90.
16. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996;7:1106-22.
17. Johnson LB, Kuo P, Dafoe DC, et al. Double adult renal allografts: a technique for expansion of the cadaveric kidney donor pool. Surgery 1996;120:583-4.
18. Kaisiske BL, Synder J. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002;13:1067-72.
19. Landowne M, Brandfonbrener M, Shock NW. The relation of age to certain measures of performance of the heart and circulation. Circulation 1955;12:567-76.
20. Brandfonbrener M, Landowne M, Shock NW. Changes in cardiac output with age. Circulation 1955;12:557-66.
21. Wahba W. Influence of aging on lung function: clinical significance of changes from age twenty. Anesth Analg 1983;62:764-76.
22. Dhar S, Shastri S, Lenora RAK. Aging and the respiratory system. Symp Geriatr Med 1976;60:1121-39.
23. Mazziotti A, Cesco M, Grazi GL, et al. Successful liver transplantation using an 87-year old donor. Hepatogastroenterology 1999;46:1819-22.
24. Valerius W, Lewis D. Organ recovery from an 84-year old donor: a case study. J Transplant Coordination 1997;7:211-3.
25. Tauchi H, Sato T. Hepatic cells of the aged. Amsterdam: Elsevier; 1978:3-19.
26. Salem SAM, Rajjayabun P, Shepherd AMM, et al. Reduced induction of drug metabolism in the elderly. Age Ageing 1978;7:68-73.
27. D'Amico TA, Meyers C, Kuotlas TC, et al. Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. J Thorac Cardiovasc Surg 1995;110:746-51.
28. Oja AO, Leichtman AL, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000;36:153-9.
29. Becker YT, Leverson G, D'Alessandro AM, et al. Diabetic kidneys can safely expand the donor pool. Transplantation 2002;74:141-5.
30. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002;73:325-30.
31. Wachs ME, Amend W, Ascher NL, et al. The risk of transmission of Hepatitis B from HBsAg-, HBcAb-, HBIgM- organ donors. Transplantation 1995;59:230-4.
32. Pereira BJ, Milford EL, Kirkman RL, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992;327:910-15.
33. Marroquin CE, Marino G, Kuo PC, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001;7:762-8.
34. Weber M, Dindo D, Demartines N, et al. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002;347:248-55.
35. Murray JE. Reminiscences for the "50-year retrospective" of transplantation. Transplant Proc 1999;31:34.
36. Ratner LE, Ciseck L, Moore RG, et al. Laparoscopic live donor nephrectomy. Transplantation 1995;60:1047-9.
37. Waller JR, Veitch P, Nicholson ML. Laparoscopic live donor nephrectomy. Transplant Proc 2001;33:3787-8.
38. Kuo PC, Johnson LB, Sitzmann JV. Laparoscopic donor nephrectomy with a 23-hour stay: a new standard for transplant surgery. Ann Surg 2000;231:772-9.
39. Swartz DE, Cho E, Flowers JL, et al. Laparoscopic right donor nephrectomy: technique and comparison with left nephrectomy. Surg Endosc 2001;15:1390-4.
40. Wolf JS, Merion R, Leichtman AB, et al. Randomized control trial of hand-assisted versus open surgical live donor nephrectomy. Transplantation 2001;72:284-90.
41. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989;2: 497.
42. Strong RW, Lynch S, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990;322:1505-7.
43. Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg 1991;214: 428-39.
44. Yamaoka Y, Washida M, Honda K, et al. Liver transplantation using a right lobe graft from a living donor. Transplantation 1994;57:1127-30.
45. Kiuchi T, Inomata Y, Uemoto S, et al. Living donor liver transplantation in Kyoto. Clin Transplant 1997:191-8.
46. Lo CM, Fan ST, Liu CL, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997;226:261-70.
47. Chen CL, Chen YS, Liu PP, et al. Living related donor liver transplantation. J Gastroenterol Hepatol 1997;12:s342-5.
48. Wachs ME, Bak TE, Karrer FM, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998;66:1313-6.
49. Marcos A, Fisher R, Ham JM, et al. Right lobe living donor liver transplantation. Transplantation 1999;68:798-803.
50. Sugawara Y, Makuuchi M, Imamura H, et al. Outflow reconstruction in recipients of right liver grafts from living donors. Liver Transpl 2002;8:167-8.
51. Emre S. Living donor liver transplantation. Transplant Proc 2001;33:3456-7.
52. McCaughan GW, Lynch S. Adult-living donor liver transplantation: another Pandora's box? MJA 2001;175:179-80.
53. Trotter J, Talamantes M, McClure M, et al. Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. 2001;7:485-93.
54. Reemtsma K, McKraken B, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg 1964;160:384-410.
55. Bailey LL, Nehlsen-Cannarella SL, Doroshow RW, et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 1986;315:949-51.
56. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993;341:65-71.
57. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995;1:423-7.
58. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha 1,3-galactosyl-transferase gene in cloned pigs. Nat Biotechnol 2002;20:251-5.
59. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nature Med 1997;3:282-6.
60. Chapman L. Xenotransplantation: benefits and risks. Emerg Infect Dis 2001; 7(suppl 3):545.
61. Shivalkar B, VanLoon J, Wieland W, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87:230-9.
62. Bittner H, Kendall S, Chen E, et al. The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. J Heart Lung Transplant 1996;15:764-77.
63. Power B, VanHeerden P. The physiological changes associated with brain death-current concepts and implications for treatment of the brain dead organ donor. Anaesth Intensiv Care 1995;23:26-36.
64. Goldstein B, Toweill D, Lai S, et al. Uncoupling of the autonomic and cardiovascular systems in acute brain injury. Am J Physiol 1998;275:R1287-92.
65. Herijgers P, Leunens V, Tjandra-Maga TB, et al. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 1996;62:330-5.
66. Pratschke J, Wilhelm MJ, Kusaka M, et al. Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transplant Proc 1999;31:1003-5.
67. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997;29:3773-5.
68. Marshall VC. Pathophysiology of brain death: effects on allograft function. Transplant Proc 2001;33:845.
69. Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation, 1999;67:343.
70. Gramm HJ, Zimmermann J, Meinhold H, et al. Hemodynamic responses to noxious stimuli in brain-dead organ donors. Intensive Care Med 1992;18:493.
71. Darracott-Cankovic S, Stoven PG, Wheeldon D, et al. Effect of donor heart damage on survival after transplantation. Eur J Cardio Thoracic Surg 1989;3:525-32.
72. Birks EJ, Burton PB, Owen VJ, et al, Molecular and cellular mechanisms of donor heart dysfunction. Transplant Proc 2001;33:2749-51.
73. Novitzky D, Horack A, Cooper DA, et al. Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc 1989;21:2567-9.
74. Kolin A, Norris JW. Myocardial damage from acute cerebral lesions. Stroke 1984;15:990-3.
75. Cooper DKC, Novitsky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989;71:261-6.
76. Wicomb W, Cooper D, Lanza R, et al. The effects of brain death and 24 hours' storage by hypothermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg 1986;91:896-909.
77. Novitsky D, Wincomb W, Cooper DKC, et al. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J Heart Transplant 1984;4:63-9.
78. Dujardin KS, McCully RB, Wijdicks EF, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 2001;20:350-7.
79. Szabo G, Hackert T, Sebening C, et al. Role of neural and humoral factors in hyperdynamic reaction and cardiac dysfunction following brain death. J Heart Lung Transplant 2000;19:683-93.
80. Szabo G, Sebening C, Hackert T, et al. Effects of brain death on myocardial function and ischemic tolerance of potential donor hearts. J Heart Lung Transplant 1998;17:921.
81. Szabo G, Hackert T, Buhmann V, et al. Downregulation of myocardial contractility via intact ventriculoarterial coupling in the brain dead organ donor. Eur J Cardiothorac Surg 2001;20:170-6.
82. Herijgers P, Flameng W. The effect of brain death on cardiovascular function in rats: part II. Cardiovasc Res 1998;38:107-15.
83. Herijgers P, Borgers M, Flameng W. The effect of brain death on cardiovascular function in rats: Part I. Is the heart damaged?. Cardiovasc Res 1998;38:98.
84. Wheeldon DR, Potter CD, Oduro A, et al. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995;14:734-42.
85. Yeh TJ, Wechsler AS, Graham LJ, et al. Acute brain death alters left ventricular myocardial gene expression. J Thorac Cardiovasc Surg 1999;117:365-74.
86. Wilhelm MJ, Pratschke J, Beato F, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000;102:2426-33.
87. Birks EJ, Yacoub MH, Burton PS, et al. Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 2000;70:1498-506.
88. Howlett TA, Keogh AM, Perry L, et al. Anterior and posterior pituitary function in brainstem dead-donors. Transplantation 1989;47:828-34.
89. Griepp RB, Stinson EB, Clark DA, et al. The cardiac donor. Surg Gynecol Obstet 1971;133:792-8.
90. Hosenpud JD, Novick RJ, Breen TJ, et al. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report: 1994. J Heart Lung Transplant 1994;13:561-70.
91. Orlowski JP, Spees EK. Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc 1993;25:1535.
92. Nagareda T, Kinoshita Y, Tanaka A, et al. Clinicopathology of kidneys from brain-dead patients treated with vasopressin and epinephrine. Kidney Int 1993;43: 1363-70.
93. van Der Hoeven JA, Ploeg RJ, Postema F, et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation 1999;68: 1884-90.
94. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000;69:405-10.
95. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001;12:2474-81.
96. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000;232:263-71.
97. Muruve NA, Helling TS, Luger AM, et al. Effect of donor brain-death duration on graft outcome. Transplant Proc 2001;33:2980-1.
98. Pratschke J, Wilhelm MJ, Kusaka M, et al. Acute rejection of rat renal allografts is accelerated by donor brain death. Transplant Proc 1999;31(1-2):874-75.
99. Wilhelm MJ, Pratschke J, Kusaka M, et al. Donor brain death affects tempo and intensity of acute rejection of rat chronic allografts. Transplant Proc 1999;31(1-2): 1008-9.
100. Kunzendorf U, Hohenstein B, Oberbarnscheid M, et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2002;2:292-94.
101. Koo DD, Welsh KI, McLaren AJ, et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int 1999;56:1551-9.
102. Pratschke J, Kofla G, Wilhelm MJ, et al. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001;234:732-40.
103. Compagnon P, Wang H, Lindell SL, et al. Brain death does not affect hepatic allograft function and survival after orthotopic transplantation in a canine model. Transplantation 2002;73:1218-27.
104. Nagareda T, Kinoshita Y, Tanaka A, et al. Clinicopathological study of livers from brain-dead patients treated with a combination of vasopressin and epinephrine. Transplantation 1989;47:792-7.
105. Sato T, Asanuma Y, Yasui O, et al. Impaired hepatic mitochondrial function reserve in brain-dead pigs. Transplant Proc 1998;30:4351-5.
106. Imai K, Sato K, Takahashi T, et al. Experimental evaluation of hepatic circulation, energy metabolism, and morphologic changes in brain death. Transplant Proc 1998;30:3282-3.
107. Okamoto S, Corso CO, Nolte D, et al. Impact of brain death on hormonal homeostasis and hepatic microcirculation of transplant organ donors. Transplant Int 1998;11:S404-7.
108. Okamoto S, Leiderer R, Yamamoto Y, et al. Histomorphometric analysis of the liver in brain-dead donors. Transplant Proc 2001;33:869.
109. van Der Hoeven JA, Ter HG, Molema G, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000;232:804-13.
110. Lopau K, Mark J, Schramm L, et al. Hormonal changes in brain death and immune activation in the donor. Transplant Int 2000;13:S282-5.
111. van Der Hoeven JA, Lindall S, Van SR, et al. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation 2001;72: 1632-6.
112. Novitzky D, Cooper DK, Morrell D, et al. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45:32-6.
113. Sazontseva IE, Kozlov I, Moisuc YG, et al. Hormonal response to brain death. Transplant Proc 1991;23:2467.
114. Kinoshita Y, Yahata K, Yoshioka T, et al. Long-term renal preservation after brain death maintained with vasopressin and epinephrine. Transplant Int 1990;3:15-8.
115. Yoshioka T, Sugimoto H, Uenishi M, et al. Prolonged haemodynamic maintenance by the combined administration of vasopressin and epinephrine in brain death: a clinical study. Neurosurgery 1986;18:565-7.
116. Novitsky D, Cooper DK, Muchmore JS, et al. Pituitary function in brain-dead patients. Transplantation 1989;48:1078-9.
117. Goarin J, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996;83:41-7.
118. Scheinkestel C, Tuxen D, Cooper D, et al. Medical management of the (potential) organ donor. Anaesth Intensiv Care 1995;23:51-9.
119. Wheeldon DR, Potter CD, Dunning J, et al. Haemodynamic correction in multiorgan donation. Lancet 1992;339:1175.
120. Novitzky D, Cooper D, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987;43: 852-64.
121. Brunicardi FC, Dyen Y, Brostrom L, et al. The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolated perfused human pancreas. Pancreas 2000;21:203-11.
122. Masson F, Thicoipe M, Gin H, et al. The endocrine pancreas in brain-dead donors: a prospective study in 25 patients. Transplantation 1993;56:363-7.
123. Plotkin J. The diagnosis and management of brain-dead and non-heartbeating organ donors. In: GAMM, Plotkin J, Coursin D, Pearl R, Prough D, editors. Critical care medicine: perioperative management. Philadelphia: Lippincott-Raven; 1997:p.273-83.
124. Black P. Brain death (part 1 of 2). N Engl J Med 1978;299:338-44.
125. Black P. Brain death (part 2 of 2). N Engl J Med 1978;299:393-401.
126. Lutz-Dettinger N, de Jaeger A, Kerremans I. Care of the potential pediatric organ donor. Pediatr Clin North Am 2001;48:715-49.
127. Soifer B, Gelb A. The multiple organ donor: identification and management. Ann Intern Med 1989;110:814-23.
128. Pennefather SH, Bullock R, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993;56:1418-22.
129. Pennefather SH, Bullock R, Mantel D, et al. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995;59:58-62.
130. Potter CD, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant 1995;14:59-65.
131. Day L. How nurses shift from care of a brain-injured patient to maintenance of a brain-dead organ donor. Am J Crit Care 2001;10:306-12.
132. Parry A, Higgins R, Wheeldon DR, et al. The contribution of donor management and modified cold blood lung perfusate to post-transplant lung function. J Heart Lung Transplant 1999;18:121-6.
133. Emery SF, Robertson KM. Organ procurement and preparation for transplantation. In: Wijdicks E, editor. Brain death. Philadelphia: Lippincott Williams and Wilkins; 2001:p.189-213.
134. Groeneveld ABJ, Thijis L. Hypovolemic shock. Parrillo JE, editor. Critical care medicine. St. Louis: Mosby-Year Book; 1995:p.387-418.
135. Cowley AW Jr, Monos E, Guyton AC. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res 1974;34:504-14.
136. Manaka D, Okamoto R, Yokoyama T, et al. Maintenance of liver graft viability in the state of brain death: synergistic effects of vasopressin and epinephrine on hepatic energy metabolism in brain-dead dogs. Transplantation 1992;53:545-50.
137. Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999;100: 11244-6.
138. Kinsara A. Guidelines for cardiopulmonary resuscitation emergency cardiovascular care. Circulation 2000;28:E45.
139. Ramos HC, Lopez R. Critical care management of the brain-dead organ donor. Curr Opin Organ Transplant 2002;7:70-5.
140. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
141. Cummings J, Houck J, Lichtenfeld D. Positive effect of aggressive resuscitative efforts on cadaver lung procurement. J Transplant Coordination 1995;5:103-6.
142. MeElhinney DB, Khan J, Babcock WD, et al. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant 2001;15:68-71.
143. Frost A. Donor criteria and evaluation. 1997;18:231-7.
144. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998;352:1178-81.
145. Kumar D, McAllister F. Rhabdomyolysis complicating unrecognized hypophosphatemia in an alcoholic patient. Can J Gastroenterol 1999;13:165-7.
146. Mariot J, Sadoune L, Jacob F. Hormone levels, hemodynamics and metabolism in brain dead organ donors. Transplant Proc 1995;27:793-4.
147. Cooper DKC, Basker M. Physiologic changes following brain death. Transplant Proc 1999;31:1001-2.
148. Novitzky D. Donor management: state of the art, Transplant Proc 1997;29:3773-5.
149. Follette DM, Rudich S, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-9.
150. Hesse UJ, Sutherland DE. Influence of serum amylase and plasma glucose levels in pancreas cadaver donors on graft function in recipients. Diabetes 1989;38:1-3.
151. Tian YH, Shafer T, Sckell A, et al. Adenosine deaminase inhibition attenuates reperfusion low flow and improves graft survival after rat liver transplantation. Transplantation 2000;69:2277-81.
152. Lanir AJ, Jenkins R, Caldwell K, et al. Hepatic transplantation survival: correlation with adenine nucleotide level in donor. Hepatology 1988;8:471-5.
153. Singer P, Cohen J, Cynober L. Effect of nutritional state of brain-dead organ donor on transplantation. Nutrition 2001;17:11-2.
154. Van de Velde M, Wouters PF, Rolf N, et al. Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs. Cardiovasc Res 1996;32: 1008-15.
155. Kozlowski LM. Case study in identification and maintenance of an organ donor. Heart Lung 1988;17:366-71.
156. Noah P, Morgan S. Organ/tissue donation request: a multidisciplinary approach. Crit Care Nurs Q 1999;22:30-8.